|
115
|
526
|
4k3jB |
Crystal structure of onartuzumab fab in complex with met and hgf-beta |
|
115
|
601
|
4kroA |
Nanobody/vhh domain ega1 in complex with the extracellular region of egfr |
|
31
|
199
|
4k9eC |
Crystal structure of kit d4d5 fragment in complex with anti-kit antibodies fab79d |
|
80
|
281
|
4knbA |
C-met in complex with osi ligand |
|
86
|
324
|
4jrvA |
Crystal structure of egfr kinase domain in complex with compound 4c |
|
19
|
208
|
4j23A |
Low resolution crystal structure of the fgfr2d2d3/fgf1/sr128545 complex |
|
86
|
324
|
4i23A |
Crystal structure of the wild-type egfr kinase domain in complex with dacomitinib (soaked) |
|
86
|
324
|
4jq8A |
Crystal structure of egfr kinase domain in complex with compound 4b |
|
82
|
287
|
4i20A |
Crystal structure of monomeric (v948r) primary oncogenic mutant l858r egfr kinase domain |
|
88
|
299
|
4j99A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659t mutation. |
|
90
|
315
|
4i22A |
Structure of the monomeric (v948r)gefitinib/erlotinib resistant double mutant (l858r+t790m) egfr kinase domain co-crystallized with gefitinib |
|
91
|
297
|
4j97A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659e mutation identified in endometrial cancer. |
|
92
|
315
|
4i24A |
Structure of t790m egfr kinase domain co-crystallized with dacomitinib |
|
15
|
81
|
4hwuA |
Crystal structure of the ig-c2 type 1 domain from mouse fibroblast growth factor receptor 2 (fgfr2) [nysgrc-005912] |
|
91
|
298
|
4j95A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic k659n mutation responsible for an unclassified craniosynostosis syndrome in space group c2. |
|
99
|
301
|
4ibmA |
Crystal structure of insulin receptor kinase domain in complex with an inhibitor irfin-1 |
|
100
|
304
|
4j98A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the gain-of-function k659q mutation. |
|
90
|
297
|
4k33A |
Crystal structure of fgf receptor 3 (fgfr3) kinase domain harboring the k650e mutation, a gain-of-function mutation responsible for thanatophoric dysplasia type ii and spermatocytic seminoma |
|
99
|
306
|
4j96A |
Crystal structure of fgf receptor 2 (fgfr2) kinase domain harboring the pathogenic gain-of-function k659m mutation identified in cervical cancer. |
|
77
|
317
|
4i21A |
Crystal structure of l858r + t790m egfr kinase domain in complex with mig6 peptide |
|
85
|
324
|
4jr3A |
Crystal structure of egfr kinase domain in complex with compound 3g |
|
93
|
305
|
4iwdA |
Structure of dually phosphorylated c-met receptor kinase in complex with an mk-8033 analog |
|
70
|
514
|
4k0vA |
Structural basis for angiopoietin-1 mediated signaling initiation |
|
81
|
292
|
4joaA |
Crystal structure of human anaplastic lymphoma kinase in complex with 7-azaindole based inhibitor |
|
86
|
324
|
4jq7A |
Crystal structure of egfr kinase domain in complex with compound 2a |
|
92
|
287
|
4i1zA |
Crystal structure of the monomeric (v948r) form of the gefitinib/erlotinib resistant egfr kinase domain l858r+t790m |
|
24
|
177
|
4hrmA |
Structural basis for eliciting a cytotoxic effect in her2-overexpressing cancer cells via binding to the extracellular domain of her2 |
|
50
|
190
|
4hrlC |
Structural basis for eliciting a cytotoxic effect in her2-overexpressing cancer cells via binding to the extracellular domain of her2 |
|
9
|
71
|
4hrnC |
Structural basis for eliciting a cytotoxic effect in her2-overexpressing cancer cells via binding to the extracellular domain of her2 |
|
81
|
282
|
4hjoA |
Crystal structure of the inactive egfr tyrosine kinase domain with erlotinib |
|
85
|
288
|
4gt4A |
Structure of unliganded, inactive ror2 kinase domain |
|
89
|
296
|
4gt5A |
Crystal structure of the inactive trka kinase domain |
|
90
|
295
|
4gk3A |
Human epha3 kinase domain in complex with ligand 87 |
|
87
|
295
|
4gk2A |
Human epha3 kinase domain in complex with ligand 66 |
|
76
|
321
|
4g5pA |
Crystal structure of egfr kinase t790m in complex with bibw2992 |
|
0
|
7
|
4gfuF |
Ptpn18 in complex with her2-py1248 phosphor-peptides |
|
84
|
321
|
4g5jA |
Crystal structure of egfr kinase in complex with bibw2992 |
|
89
|
281
|
4gg7A |
Crystal structure of cmet in complex with novel inhibitor |
|
87
|
295
|
4gk4A |
Human epha3 kinase domain in complex with ligand 90 |
|
84
|
281
|
4gg5A |
Crystal structure of cmet in complex with novel inhibitor |
|
123
|
527
|
4fwwA |
Crystal structure of the sema-psi extracellular domains of human ron receptor tyrosine kinase |
|
92
|
310
|
4fnzA |
Crystal structure of human anaplastic lymphoma kinase in complex with piperidine-carboxamide inhibitor 2 |
|
90
|
295
|
4g2fA |
Human epha3 kinase domain in complex with compound 7 |
|
98
|
310
|
4focA |
Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 2 |
|
102
|
322
|
4fnwA |
Crystal structure of the apo f1174l anaplastic lymphoma kinase catalytic domain |
|
93
|
302
|
4fnyA |
Crystal structure of the r1275q anaplastic lymphoma kinase catalytic domain in complex with a benzoxazole inhibitor |
|
67
|
279
|
4feqA |
Inhibitor bound structure of the kinase domain of the murine receptor tyrosine kinase tyro3 (sky) |
|
100
|
310
|
4fobA |
Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 1 |
|
100
|
321
|
4fodA |
Crystal structure of human anaplastic lymphoma kinase in complex with acyliminobenzimidazole inhibitor 36 |
|
168
|
613
|
3qwqA |
Crystal structure of the extracellular domain of the epidermal growth factor receptor in complex with an adnectin |
